Over the last 12 months, STERIS insiders reported no purchases and 3 sales totaling $1.6M across SEC Form 4 filings. 67% of the activity was filed under pre-arranged 10b5-1 trading plans.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Zangerle John AdamSr. VP, Gen Counsel, and Sec. · O | ▼ Sale | 1,419 | $209.28 | $297K | -3.9% | plan |
| Jun 5, 2026 | Carestio Daniel APresident and CEO · O·D | ▼ Sale | 4,428 | $213.82 | $947K | -6.5% | plan · 2 tranches |
| Jun 2, 2026 | Breeden Richard CD | ▼ Sale | 1,481 | $209.51 | $310K | -3.7% | — |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $STE feed.